Jianguo Lin

2.8k total citations
135 papers, 2.3k citations indexed

About

Jianguo Lin is a scholar working on Oncology, Radiology, Nuclear Medicine and Imaging and Biomedical Engineering. According to data from OpenAlex, Jianguo Lin has authored 135 papers receiving a total of 2.3k indexed citations (citations by other indexed papers that have themselves been cited), including 58 papers in Oncology, 49 papers in Radiology, Nuclear Medicine and Imaging and 41 papers in Biomedical Engineering. Recurrent topics in Jianguo Lin's work include Radiopharmaceutical Chemistry and Applications (43 papers), Nanoplatforms for cancer theranostics (36 papers) and Bone health and treatments (22 papers). Jianguo Lin is often cited by papers focused on Radiopharmaceutical Chemistry and Applications (43 papers), Nanoplatforms for cancer theranostics (36 papers) and Bone health and treatments (22 papers). Jianguo Lin collaborates with scholars based in China, Fiji and Poland. Jianguo Lin's co-authors include Ling Qiu, Gao‐Chao Lv, Qingzhu Liu, Deju Ye, Shineng Luo, Ke Li, Yinxing Miao, Ke Li, Ying Peng and Zheng Huang and has published in prestigious journals such as Journal of the American Chemical Society, Angewandte Chemie International Edition and Nature Communications.

In The Last Decade

Jianguo Lin

129 papers receiving 2.3k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Jianguo Lin China 26 853 676 632 533 465 135 2.3k
Zhanhong Wu United States 29 664 0.8× 855 1.3× 687 1.1× 473 0.9× 980 2.1× 79 3.1k
Jeongsoo Yoo South Korea 27 505 0.6× 582 0.9× 373 0.6× 454 0.9× 1.0k 2.2× 81 2.2k
Yoshinori Koyama Japan 31 1.2k 1.4× 1.4k 2.0× 342 0.5× 811 1.5× 417 0.9× 76 3.4k
Cinzia Imberti United Kingdom 20 503 0.6× 427 0.6× 907 1.4× 610 1.1× 344 0.7× 33 2.0k
Joseph Lau Canada 29 1.6k 1.9× 1.2k 1.7× 671 1.1× 771 1.4× 745 1.6× 65 3.6k
Lianglin Zhang United States 24 755 0.9× 1.4k 2.0× 539 0.9× 405 0.8× 365 0.8× 42 2.8k
Qizhen Cao United States 24 1.4k 1.6× 1.2k 1.7× 574 0.9× 1.1k 2.1× 847 1.8× 32 3.6k
Gary Gellerman Israel 22 354 0.4× 850 1.3× 322 0.5× 235 0.4× 232 0.5× 85 1.6k
Lina He China 17 778 0.9× 684 1.0× 471 0.7× 577 1.1× 490 1.1× 52 2.2k
Charles J. Smith United States 29 350 0.4× 634 0.9× 793 1.3× 263 0.5× 1.1k 2.3× 73 2.5k

Countries citing papers authored by Jianguo Lin

Since Specialization
Citations

This map shows the geographic impact of Jianguo Lin's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Jianguo Lin with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Jianguo Lin more than expected).

Fields of papers citing papers by Jianguo Lin

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Jianguo Lin. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Jianguo Lin. The network helps show where Jianguo Lin may publish in the future.

Co-authorship network of co-authors of Jianguo Lin

This figure shows the co-authorship network connecting the top 25 collaborators of Jianguo Lin. A scholar is included among the top collaborators of Jianguo Lin based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Jianguo Lin. Jianguo Lin is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Li, Ke, Tingfang Wang, Yi Zou, et al.. (2025). Novel Dual-Functional Half-Curcumin Analogues as a Fluorescent and PET Probe for β-Amyloid Imaging in the Alzheimer’s Disease APP/PS1 Model. ACS Chemical Neuroscience. 16(3). 365–373. 1 indexed citations
2.
Miao, Yinxing, Yuqi Wang, Yefeng Chen, et al.. (2025). Pretargeted Multimodal Tumor Imaging by Enzymatic Self-Immobilization Labeling and Bioorthogonal Reaction. Journal of the American Chemical Society. 147(3). 2809–2821. 11 indexed citations
3.
Li, Ke, et al.. (2025). A Self‐immobilizing PET Tracer for Imaging of H2O2 Level in the Brain. Chinese Journal of Chemistry. 43(16). 1938–1944. 1 indexed citations
5.
Yang, Jichen, et al.. (2025). Preclinical Evaluation Study of 68 Ga-Labeled PSMA-Targeted Dimer Probe. Chemical & Biomedical Imaging. 4(1). 54–63.
6.
Yang, Xiaofeng, Gao‐Chao Lv, Ying Peng, et al.. (2025). Synthesis and biological evaluation of a 68Ga-labeled glucose derivative PET probe [68Ga]Ga-NOTA-SDG. Applied Radiation and Isotopes. 223. 111893–111893.
7.
Li, Ke, Qiqi Wang, Xiaoqing Gao, et al.. (2024). Targeted delivery of activatable 131I-radiopharmaceutical for sustained radiotherapy with improved pharmacokinetics. Journal of Controlled Release. 373. 967–977. 3 indexed citations
8.
Gao, Xiaoqing, Xiaofeng Yang, Jing Fang, et al.. (2024). Legumain-Triggered Macrocyclization of Radiofluorinated Tracer for Enhanced PET Imaging. Bioconjugate Chemistry. 35(5). 665–673.
10.
Shao, Xueting, et al.. (2024). Screening potential biomarkers for acute respiratory infectious diseases from antipyretics, antiviral, and antibiotics in wastewater. The Science of The Total Environment. 954. 176714–176714. 1 indexed citations
11.
Liu, Qingzhu, et al.. (2024). Preclinical evaluation of 68 Ga-labeled peptide CK2 for PET imaging of NRP-1 expression in vivo. European Journal of Nuclear Medicine and Molecular Imaging. 51(7). 1826–1840. 9 indexed citations
12.
Lin, Jianguo, et al.. (2024). Pgam5 aggravates hyperglycemia-induced myocardial dysfunction through disrupting Phb2-dependent mitochondrial dynamics. International Journal of Medical Sciences. 21(7). 1194–1203. 6 indexed citations
14.
Xu, Liang, Lixia Zhang, Beibei Liang, et al.. (2023). Design, Synthesis, and Biological Evaluation of a Small-Molecule PET Agent for Imaging PD-L1 Expression. Pharmaceuticals. 16(2). 213–213. 16 indexed citations
15.
Li, Ke, et al.. (2023). Cerenkov radiation induced chemo-photodynamic therapy using ROS-responsive agent. Journal of Photochemistry and Photobiology A Chemistry. 439. 114641–114641. 3 indexed citations
16.
Zhang, Guojin, et al.. (2022). 68Ga-Labeled Cystine Knot Peptide Targeting Integrin αvβ6 for Lung Cancer PET Imaging. Molecular Pharmaceutics. 19(7). 2620–2628. 9 indexed citations
17.
Wang, Xiuting, et al.. (2022). Optimized molecular design of PET probe for the visualization of γ-glutamyltranspeptidase activity in tumors. New Journal of Chemistry. 46(21). 10219–10228. 3 indexed citations
18.
Li, Hang, Xiuting Wang, Yinxing Miao, et al.. (2021). Development of biotin-tagged near-infrared fluorescence probes for tumor-specific imaging. Journal of Photochemistry and Photobiology B Biology. 217. 112172–112172. 7 indexed citations
19.
Shao, Xueting, Han Yu, Jianguo Lin, et al.. (2021). Presence of the ketamine analog of 2‐fluorodeschloroketamine residues in wastewater. Drug Testing and Analysis. 13(9). 1650–1657. 16 indexed citations
20.
Lin, Jianguo, Ling Qiu, Gao‐Chao Lv, et al.. (2016). Synthesis and preliminary biological evaluation of a 99mTc‐chlorambucil derivative as a potential tumor imaging agent. Journal of Labelled Compounds and Radiopharmaceuticals. 60(2). 116–123. 13 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026